Professional Documents
Culture Documents
Fosroc Structuro W435: Constructive Solutions
Fosroc Structuro W435: Constructive Solutions
Fosroc Structuro W435: Constructive Solutions
Self compacting concrete along with Auramix V200 Appearance : Light yellow coloured liquid
Specific gravity : 1.07 @ 25°C
Pre-cast concrete
Chloride content : Nil to BS 5075 / BS:EN934
Concrete requiring long workability retention
High performance mass concrete Dosage Guidelines
For hydroelectric dam projects
The optimum dosage of Structuro W435 to meet specific
requirements should always be determined by trials using
Advantages
the materials and conditions that will be experienced in use.
Increased early and ultimate compressive strengths
Dosage guideline is between 0.2 to 2.0% by weight of
Increased flexural strength
cement or cementitious materials including PFA, GGBFS &
Improved adhesion to reinforcing and stressing steel microsilica.
Lower permeability Dosages outside the above dosage guidelines can be used
to meet particular concrete mix requirements. Please con-
Increased resistance to aggressive atmospheric
tact Fosroc for advice in such cases..
conditions
Effects of overdosing
Reduced shrinkage and creep
Overdosage may cause delay in the setting time.
Increased durability
Technical support
Standards compliance
Fosroc provides a technical advisory service for on-site
Structuro W435 conforms with BS 5075, BS:EN 934-2 and assistance and advice on mix design, admixture selection,
with ASTM C494 as Type F and G depending on dosage evaluation trials and dispensing equipment.
used.
Description
Structuro W435 is suitable for use with all types of Portland Precautions
cements and cement replacement materials such as PFA,
Health and safety
GGBFS, SRC and microsilica.
Structuro W435 does not fall into the hazard classifications
Mixing
of current regulations. However, it should not be swallowed
When used at the mixing plant, Structuro W435 should be or allowed to come into contact with skin and eyes.
added in the mixing water. Suitable protective gloves and goggles should be worn.
In some instances, e.g. addition to ready mix concrete on Splashes on the skin should be removed with water. In case
site, Structuro W435 can be added directly in the truck mixer of contact with eyes rinse immediately with plenty of water
and mixed at maximum speed for an extra 5 minutes. and seek medical advice. If swallowed seek medical atten-
For high flow Self compacting concrete, Auramix V200 can tion immediately - do not induce vomiting.
be used at a dosage between 0.5 to 1.5 Litres per cubic For further information consult the Material Safety Data
meter. Sheet available for this product.
Dispensing Fire
The correct quantity of Structuro W435 should be measured Structuro W435 is water based and non-flammable.
by means of a recommended dispenser. The admixture
should then be added to the concrete with the mixing water Cleaning and disposal
to obtain the best results. Contact Fosroc for advice regard- Spillages of Structuro W435 should be absorbed onto sand,
ing suitable equipment and its installation. earth or vermiculite and transferred to suitable containers.
Remnants should be hosed down with large quantities of
Estimating water.
Important note
Fosroc products are guaranteed against defective materials and manufacture and are sold subject to its standard Conditions for the Supply of
Goods and Service. All Fosroc datasheets are updated on a regular basis. It is the user’s responsibility to obtain the latest version.
Head Office
telephone: (+9714) 2039699 fax: (+9714) 2859649 email: agf@fosroc.com
Al Gurg Fosroc LLC
Regional offices
Post Box 657, Dubai Abu Dhabi, Al Gurg Fosroc telephone: 673 1779 fax: 673 1449 email: abudhabi@fosroc.com
Bahrain, YBA Kanoo telephone: 17738200 fax: 17732828 email: bahrain@fosroc.com
United Arab Emirates Kuwait, Boodai telephone: 4817618 fax: 4832124 email: kuwait@fosroc.com
Oman, Al Amana telephone: 24815080 fax: 24817554 email: oman@fosroc.com
www.fosroc.com Qatar, Tadmur telephone: 4665501 fax: 4664147 email: qatar@fosroc.com
UAE/0654/15/C